B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SPHK2

MOLECULAR TARGET

sphingosine kinase 2

UniProt: Q9NRA0NCBI Gene: 568484 compounds

SPHK2 (sphingosine kinase 2) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SPHK2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1dimethylspingosine2.4811
2pachastrissamine1.956
3Sphingosine0.691
4bdb chembl24071970.691

About SPHK2 as a Drug Target

SPHK2 (sphingosine kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented SPHK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SPHK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.